Small RNA from surrounding cells promotes triple-negative breast cancer growth

by National Research Council of Science and Technology

edited by Sadie Harley, reviewed by Andrew Zinin

Sadie Harley

Scientific Editor

Meet our editorial team
Behind our editorial process

Andrew Zinin

Chief Editor

Meet our editorial team
Behind our editorial process Editors' notes

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

trusted source

proofread

The GIST Add to Preferred Sources

Some 15% of all breast cancer cases are considered particularly difficult to treat because they grow rapidly and carry a high risk of recurrence. Because targeted therapies used for other types of breast cancer have limited applicability to this subtype, treatment has relied largely on chemotherapy. However, drug resistance and recurrence have created an urgent need for new treatment and diagnostic approaches.

A research team led by Dr. Hyun-Soo Cho at the Korea Research Institute of Bioscience and Biotechnology (KRIBB), in collaboration with Professor Keun Hur's team at Kyungpook National University, has identified how miR-1290, a type of microRNA transferred from fibroblasts surrounding tumors, promotes the growth of triple-negative breast cancer cells.

The work is published in the journal Signal Transduction and Targeted Therapy.

Fibroblasts normally provide structural support for tissues and help repair wounds. In the environment surrounding a tumor, however, they can instead support cancer growth. It remains unclear which substances these cells release to promote cancer cell growth.

The researchers focused on exosomes, tiny sacs released by cells that act like delivery packages, carrying various substances to other cells. By analyzing the contents of exosomes released by cancer-associated fibroblasts and breast cancer cells, the team identified miR-1290 as a key candidate involved in cancer growth.

When miR-1290 from fibroblasts entered triple-negative breast cancer cells, it reduced levels of TBC1D4, a protein that helps suppress tumor growth. This activated growth signals within the cancer cells, increased miR-1290 levels, and promoted cancer cell proliferation.

Based on this mechanism, the team proposed a new therapeutic approach that blocks the signals driving cancer cell growth. In experiments using three-dimensional cell models and animals, the researchers demonstrated that everolimus, a growth-inhibiting drug already approved for the treatment of other cancers, effectively suppressed cancer cell proliferation induced by miR-1290.

An analysis of blood miR-1290 levels in patients with breast cancer also showed that higher blood levels of miR-1290 were associated with faster cancer progression and poorer outcomes. These findings suggest that miR-1290 could serve as a blood-based biomarker for diagnosis and prognosis.

The study identifies a mechanism in the environment surrounding tumors that drives the growth of triple-negative breast cancer, a particularly challenging cancer to treat. It also opens up the possibility of repurposing an existing drug to target this mechanism.

"This study reveals the signaling pathway through which cells surrounding a tumor stimulate cancer cells," said Cho, the study's lead investigator. "We expect these findings to contribute to the development of new targeted therapies and more precise diagnostic criteria for patients with triple-negative breast cancer, whose treatment options remain limited."

More information

Jinkwon Lee et al., Breast cancer-associated fibroblast-derived exosomal miR-1290 promotes triple-negative breast cancer cell proliferation, Signal Transduction and Targeted Therapy (2026). DOI: 10.1038/s41392-026-02922-y

Key medical concepts

Triple Negative Breast NeoplasmsCancer-Associated FibroblastsEverolimus

Clinical categories

Oncology Provided by National Research Council of Science and Technology Who's behind this story?

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Andrew Zinin

Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →

Citation: Small RNA from surrounding cells promotes triple-negative breast cancer growth (2026, November 12) retrieved 12 November 2026 from https://medicalxpress.com/news/2026-11-small-rna-cells-triple-negative.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.